The global dry eye syndrome market size is projected to reach USD 7.73 billion by the end of 2026. The high prevalence of dry eye syndrome has created several opportunities for the companies operating in the market. According to a published report, titled “Dry Eye Syndrome Market Size, Share and Global Trend By Product (Anti-inflammatory and, Artificial Tears and Lubricants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Geography Forecast till 2026,” the market was worth USD 4.22 billion and will exhibit a CAGR of 6.9% during the forecast period, 2019-2026.
Dry eye syndrome is a critical disorder that possesses severe symptoms. The emphasis on the treatment of the disease, mainly due to its severity and potential to affect vision has created several growth opportunities for the companies operating in the market. The increasing investment in the R&D of treatment options associated with this disease will have a positive impact on the growth of the market in the coming years. Recent advancements in clinical trials associated with the disease, coupled with the increasing number of research and development activities will bode well for the market in the coming years. The presence of several reimbursement policies will emerge in favour of market growth.
For More Information: https://www.fortunebusinessinsights.com/dry-eye-syndrome-market-102413
Advancements in Clinical Trials Will Aid Growth
The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, the advancements in clinical trial for the rugs associated with dry eye syndrome will bode well for the companies operating in the market. Several large scale companies have made progress in ongoing clinical trials. In April 2019, a clinical trial for ‘A Study to Assess the Safety and Effectiveness of SJP-0035 for treatment of patients with dry eye syndrome has made progress and sponsored by the Senju Pharmaceutical Co., Ltd. is currently in phase-3 of clinical trials. Such advancements in drug trials will have a direct impact on the growth of the market in the coming years.
North America to Emerge Leading; Presence of Several Large Scale Companies Will Aid Growth
The report analyzes the ongoing diabetic dry eye treatment market trends across fiver major regions, including North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. Among all regions, the market in North America currently holds the largest market share. As of 2018, the market in North America was worth USD 2.42 billion and this value is likely to increase further in the coming years. The presence of several large scale companies in this region has contributed to the growth of the market in recent years.
Some of the leading companies that are operating in the global dry eye syndrome market are:
- ALLERGAN
- Alcon
- Novartis AG
- Santen Pharmaceutical Co., Ltd.
- OASIS Medical
- Sun Pharmaceutical Industries Ltd
- Otsuka Pharmaceutical Co., Ltd.
- Sentiss Pharma Pvt. Ltd.
- Johnson & Johnson Vision Care, Inc.
- VISUfarma
- Others
